Join to View Full Profile
20 York StLmp2073New Haven, CT 06510
Phone+1 203-785-6668
Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Asher Marks is a New Haven, CT-based specialist in Pediatric Hematology & Oncology with a focus on Pediatric Neuro-Oncology. He completed his medical education at Lewis Katz School of Medicine at Temple University, followed by a pediatrics residency and a fellowship in Pediatric Hematology/Oncology at Children's National Hospital/George Washington University, and a fellowship in Pediatric Neuro-Oncology at Children's National Medical Center/George Washington University. Dr. Marks has contributed to numerous publications, notably on topics such as molecular diagnostics in pediatric brain cancer and the use of virtual reality in cancer support groups. He is also involved in various clinical trials, including those on gliomas and medulloblastoma, serving as a Principal Investigator.
Education & Training
Children's National Medical Center/George Washington UniversityFellowship, Pediatric Neuro-Oncology, 2012 - 2013- Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
- Children's National HospitalResidency, Pediatrics, 2006 - 2009
Lewis Katz School of Medicine at Temple UniversityClass of 2006
Certifications & Licensure
CT State Medical License 2013 - 2026
DC State Medical License 2006 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma Start of enrollment: 2017 Apr 04
- A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
- BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas Start of enrollment: 2019 Apr 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citations"Techquity" in Pediatric, Adolescent, and Young Adult Oncology: Addressing Inequities Through Artificial Intelligence and Immersive Technologies.Vidya Puthenpura, Mary Hunter, Asher M Marks
Pediatric Blood & Cancer. 2025-10-01 - 7 citationsVirtual Reality in Medical Education.Frank D Buono, Asher Marks, Deborah Lee
Cyberpsychology, Behavior and Social Networking. 2024-06-01 - Player 2 Has Entered the Game: Extended Reality and Games for Health.Kimberly Hieftje, Asher Marks
Games for Health Journal. 2023-12-01
Press Mentions
Death, Grief, and Cicadas: How a Mother Is Helping Others Navigate LossJuly 31st, 2025
Yale Advances in Treating Primary Brain Cancers Benefit Patients and ScienceFebruary 11th, 2025- Learning What’s Possible: Daniel Colón-RíosOctober 4th, 2021
Grant Support
- Life at 100.4: An Immersive Social Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients and CaregiversTHE GLIMPSE GROUP, INC.2025–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
